Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Zinc finger protein 396 pseudogene" is a DNA sequence similar to the functional ZNF396 gene but is classified as a *pseudogene*, meaning it is not believed to encode a functional protein product. The presence of "pseudogene" and its ENSG identifier (ENSG00000271666) indicate that it is not a protein-coding gene, nor a validated therapeutic target. ZNF396 itself, when not a pseudogene, refers to a member of the SCAN domain-containing C2H2 zinc finger transcription factors, which may regulate gene expression and are highly expressed in the liver[1][4]. However, for the pseudogene, there is currently no evidence of biological function, clinical relevance, or therapeutic targeting potential. Pseudogenes of zinc finger proteins are typically remnants of gene duplication events and are not considered drug targets or relevant for biomarker development[3][4]. While ZNF396 (the protein-coding gene, ENSG00000178343) is a real gene in the "C2H2 zinc finger" and "SCAN domain" transcription factor family, the "zinc finger protein 396 pseudogene" is not expected to have a known function, aliases, or drug interactions. No entries were found in canonical target databases for the pseudogene as a target. In summary, this target is a *pseudogene* mapping to "zinc finger protein 396"; it is not a functional therapeutic target, does not encode a protein, and has no relevance for therapeutic intervention or biomarker strategy[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 396 pseudogene.